COVID-19: Good intentions do not guarantee vaccines and treatments for everyone
Sovereignty: the best medicine against COVID-19
Compulsory licenses to guarantee access to medical technologies
Remdesivir in Argentina: new patent opposition filed by Fundación GEP intends to stop Gilead’s abusive behaviour
Argentina: Fundación GEP opposed Gilead´s patent application on remdesivir
COVID19- South America: Gilead block access to coronavirus treatment for 440 million people
RedLAM in Geneva: A week of actions against the Corporate Power and to reclaim Peoples Sovereignty
Fundación GEP filed patent opposition on Hepatitis C treatment
Argentina: elimination of the Ministry of Health threatens PLHIV lives
Argentina: Stockouts of ARVs threatens continuation of HIV treatments
Hepatitis C: In Argentina INPI rejected a key patent on Sofosbuvir
The power of communities against monopolies
Eu-Mercosur Bi-Regional Association Agreement: impact of the intellectual property chapter on public procurement of medicines in Argentina
Gilead forced to withdraw Truvada® patent application in Argentina
Argentina’s Patent Office signs bilateral agreement with the US harming public health and national laws
GEP filed new opposition to patent request for Hepatitis C drug in Argentina
International Congress on Access to Medicines and Human Rights' Full Schedule
International Congress on Access to Medicines, Medical Technologies and Human Rights
Big Pharma’s court cases in Brazil & Argentina threaten national laws considered important public health safeguards in the UN HLP report
